Related Experiment Videos
Phase II evaluation of maytansine in patients with advanced head and neck cancer
Cancer Treatment Reports
|November 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clinical pharmacology and therapeutics·2013
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.
Frontiers in cell and developmental biology·2026
Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
Frontiers in pharmacology·2026
Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.
Frontiers in immunology·2026
Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.
Frontiers in pharmacology·2026